Washington, D.C., (December 4, 2018) —MedStar Heart in partnership with CardioCell has been approved to conduct an investigational new drug clinical trial, called STEMVAD at MedStar Heart & Vascular Institute. The goal of this study is to determine whether stem cell therapy improves myocardial function in patients with severe heart failure. “Innovative therapies to improve heart function and outcomes of patients with advanced heart failure are sorely needed,” said Selma Mohammed, MD, PhD. Read more.
Recent Posts
- Introduction to the Principles and Practice of Clinical Research (IPPCR)
MedStar Health is proud to be participating in The Introduction to the Principles and Practice of Cl... - MedStar Investigator Orientation—January 23, 2020
The MedStar Health Research Institute (MHRI) is offering a one-day orientation session on ... - November Peer-Reviewed Publications from MedStar Health
Congratulations to all MedStar researchers who had articles published in November 2019. The selected...
Contact
Eva Hochberger
Communications & Planning Manager
Phone: 301-560-2917
[email protected]